Related Experiment Video
Updated: Mar 3, 2026

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
2024-2025 COVID-19 mRNA Vaccine Effectiveness Against Severe Disease
Iromi Jayawardena1,2, Natalie E Dean3, Brian Witrick1,2
1Department of Public Health Sciences, Clemson University, Clemson, South Carolina, USA.
Background:
This study evaluated the effectiveness of the 2024-2025 coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccine against COVID-19 emergency department (ED) visits and hospitalizations.
Methods:
Using electronic health records from a large South Carolina health system, we emulated a target trial comparing adults aged 18 years and older who did and did not receive the 2024-2025 COVID-19 mRNA vaccine. Vaccinated individuals during September 1, 2024-March 15, 2025, were risk-set matched 1:2 to unvaccinated individuals on demographic and clinical covariates using propensity score matching. Primary outcomes were time to COVID-19 ED or more severe care and time to hospitalization through April 16, 2025, analyzed using Cox proportional hazards models.
Results:
The final matched cohort included 30,080 individuals, including 10,029 vaccinated participants. Mean age was 65.5 years, 36.5% male, 66.7% Caucasian; 85.6% had a pre-existing condition. Vaccine effectiveness against ED or more severe care was 41.3% (95% CI, 17.2%-58.4%) and 46.1% (95% CI, 13.6%-66.3%) against hospitalization.
Conclusions:
The 2024-2025 mRNA COVID-19 vaccine provided moderate protection against COVID-19 ED visits and hospitalizations among an older population with a high burden of pre-existing conditions, supporting continued efforts to improve vaccine uptake in higher-risk adults.
More Related Videos
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Related Concept Videos
Vaccinations
Nuclear Export of mRNA
Leaky Scanning
Antimicrobial Effectiveness
mRNA Stability and Gene Expression
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability